Yant S R, Zhu W, Millinoff D, Slightom J L, Goodman M, Gumucio D L
Department of Anatomy and Cell Biology, University of Michigan Medical School, Ann Arbor 48109-0616, USA.
Nucleic Acids Res. 1995 Nov 11;23(21):4353-62. doi: 10.1093/nar/23.21.4353.
PCR-assisted binding site selection was used to define the sequence characteristics of high affinity YY1 binding sites. Compilation of the sequences of 189 selected oligonucleotides containing high affinity YY1 binding sites revealed two types of core sequence: ACAT and CCAT. ACAT cores were surrounded by other invariant nucleotides, forming the consensus GACATNTT. A search of the 73 kb human beta-like globin cluster with this consensus revealed eight matching motifs, six of which were located within 1-3 kb upstream of the gamma and beta genes. CCAT-type cores were more variable in surrounding sequence context; the consensus VDCCATNWY was found to fit 89% of the selected CCAT-containing oligonucleotides. A search of the human beta globin cluster with CCAT consensus sequences revealed 171 potential YY1 binding sites. Several of these were tested directly in gel shift assays and confirmed as high affinity YY1 binding sites. Finally, a strategy called motif-based phylogenetic analysis was employed to determine which of the 179 total sites are evolutionarily conserved. This analysis permits the detection of functionally conserved binding sites despite sequence differences present between the two species. The 21 conserved sites identified will serve as important starting points in further dissection of the possible role of YY1 in globin gene regulation.
采用聚合酶链反应(PCR)辅助的结合位点选择方法来确定高亲和力YY1结合位点的序列特征。对189个含有高亲和力YY1结合位点的选定寡核苷酸序列进行汇编,发现了两种核心序列:ACAT和CCAT。ACAT核心序列被其他不变核苷酸包围,形成了共有序列GACATNTT。用该共有序列搜索73 kb的人类β样珠蛋白基因簇,发现了8个匹配基序,其中6个位于γ和β基因上游1-3 kb范围内。CCAT型核心序列在周围序列环境中变化更大;发现共有序列VDCCATNWY符合89%选定的含CCAT寡核苷酸。用CCAT共有序列搜索人类β珠蛋白基因簇,发现了171个潜在的YY1结合位点。其中几个在凝胶迁移试验中直接进行了检测,并被确认为高亲和力YY1结合位点。最后,采用一种基于基序的系统发育分析策略来确定总共179个位点中哪些在进化上是保守的。这种分析能够检测到功能保守的结合位点,尽管两个物种之间存在序列差异。确定的21个保守位点将作为进一步剖析YY1在珠蛋白基因调控中可能作用的重要起点。